Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.4% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Technology | 6.04% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
WPP
WPP
$4.44B
| $1.52K | ﹤0.01% |
38,800
+5,926
| +18% | +$234K |
|
2752
Lindblad Expeditions
LIND
$2.24B
| $1.52K | ﹤0.01% |
178,837
-21,906
| -11% | -$186K |
|
2753
Rigel Pharmaceuticals
RIGL
$716M
| $1.52K | ﹤0.01% |
63,384
+6,955
| +12% | +$171K |
|
2754
Nuvation Bio
NUVB
$2.24B
| $1.52K | ﹤0.01% |
+135,747
| New | +$1.47M |
|
2755
Orthofix Medical
OFIX
$493M
| $1.52K | ﹤0.01% |
48,750
+37,445
| +331% | +$1.16M |
|
|
VRAY
2756
DELISTED
ViewRay, Inc.
VRAY
| $1.52K | ﹤0.01% |
433,789
-2,128,694
| -83% | -$5.93M |
|
2757
CALL
Masco
MAS
$15.2B
| $1.52K | ﹤0.01% |
27,500
-45,100
| -62% | -$2.53M |
|
2758
Synopsys
SNPS
$77.3B
| $1.51K | ﹤0.01% |
7,066
-907
| -11% | -$185K |
|
|
AYX
2759
DELISTED
Alteryx Inc
AYX
| $1.51K | ﹤0.01% |
13,313
-22,916
| -63% | -$3.12M |
|
2760
CALL
HCA Healthcare
HCA
$86.8B
| $1.51K | ﹤0.01% |
12,100
+10,000
| +476% | +$1.24M |
|
|
TRNE.WS
2761
CALL
DELISTED
Trine Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A
TRNE.WS
| $1.51K | ﹤0.01% |
+125,000
| New | +$235K |
|
2762
CALL
CF Industries
CF
$18.1B
| $1.51K | ﹤0.01% |
49,100
| – | – |
|
|
AAN.A
2763
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $1.51K | ﹤0.01% |
26,616
+8,323
| +45% | +$472 |
|
2764
Ball Corp
BALL
$17B
| $1.51K | ﹤0.01% |
18,121
-46,289
| -72% | -$3.56M |
|
|
DBVT
2765
DBV Technologies
DBVT
$811M
| $1.51K | ﹤0.01% |
87,033
+52,578
| +153% | +$1.51M |
|
|
DAO
2766
Youdao
DAO
$2.02B
| $1.5K | ﹤0.01% |
58,224
-30,702
| -35% | -$1.05M |
|
2767
Saia
SAIA
$9.99B
| $1.5K | ﹤0.01% |
11,896
-19,182
| -62% | -$2.45M |
|
2768
Stantec
STN
$8.28B
| $1.5K | ﹤0.01% |
49,486
-40,207
| -45% | -$1.27M |
|
2769
CALL
Melco Resorts & Entertainment
MLCO
$2.17B
| $1.5K | ﹤0.01% |
+90,000
| New | +$1.6M |
|
2770
Prudential
PUK
$36.7B
| $1.5K | ﹤0.01% |
+53,943
| New | +$1.61M |
|
|
HONE
2771
DELISTED
HarborOne Bancorp
HONE
| $1.49K | ﹤0.01% |
+184,865
| New | +$1.58M |
|
|
ORTX
2772
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.49K | ﹤0.01% |
36,300
+14,297
| +65% | +$739K |
|
|
MNDT
2773
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.49K | ﹤0.01% |
+120,737
| New | +$1.65M |
|
2774
Agilysys
AGYS
$3.14B
| $1.49K | ﹤0.01% |
+61,613
| New | +$1.37M |
|
2775
CALL
Gossamer Bio
GOSS
$88.7M
| $1.49K | ﹤0.01% |
120,000
+110,000
| +1,100% | +$1.46M |
|
Similar funds
Millennium Management's Q3 2020 Portfolio in Review
As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Millennium Management opened 989 new positions and closed 724 in Q3 2020.
- Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.